Current Issue February 2012, Vol. 81, No. 2

Issue Highlights

  • Molecular mechanisms underlying the role of microRNAs (miRNAs) in anticancer drug resistance and implications for clinical practice
    February 2012(Vol. 81 | No. 2 | Pages 103-122)

    Elisa Giovannetti, Ayse Erozenci, Jorn Smit, Romano Danesi, Godefridus J. Peters

  • Time for a new era in the evaluation of targeted therapies for patients with chronic myeloid leukemia: Inclusion of quality of life and other patient-reported outcomes
    February 2012(Vol. 81 | No. 2 | Pages 123-135)

    F. Efficace, K. Cocks, M. Breccia, M. Sprangers, C.A. Meyers, M. Vignetti, M. Baccarani, F. Mandelli, GIMEMA and EORTC Quality of Life Group

  • Reporting of myelotoxicity associated with emerging regimens for the treatment of selected solid tumors
    February 2012(Vol. 81 | No. 2 | Pages 136-150)

    Arlene Chan, Shailendra Verma, Sibylle Loibl, Jeffrey Crawford, Mi Rim Choi, Lyndah Dreiling, Ted Vandenberg

  • Individualized therapy for patients with non-small cell lung cancer: Emerging trends and challenges
    27 January 2012

    Corey J. Langer

  • Tyrosine kinase inhibitors for elderly chronic myeloid leukemia patients: A systematic review of efficacy and safety data
    27 January 2012

    Massimo Breccia, Mario Tiribelli, Giuliana Alimena

  • Octreotide for malignant bowel obstruction: Twenty years after
    25 January 2012

    Sebastiano Mercadante, Giampiero Porzio

  • Tumour response prediction by diffusion-weighted MR imaging: Ready for clinical use?
    24 January 2012

    Linda Heijmen, Maartje C.H.M. Verstappen, Edwin E.G.W. ter Voert, Cornelis J.A. Punt, Wim J.G. Oyen, Lioe-Fee de Geus-Oei, John J. Hermans, Arend Heerschap, Hanneke W.M. van Laarhoven

  • Malnutrition in childhood cancer patients: A review on its prevalence and possible causes
    24 January 2012

    Aeltsje Brinksma, Gea Huizinga, Esther Sulkers, Willem Kamps, Petrie Roodbol, Wim Tissing

  • View More Articles in Press...

On the Cover

Cover Image

Education Zone

CROH is the official journal of the European School of Oncology (www.eso.net) and Club ESO members are entitled to a discounted subscription rate. Furthermore, CROH co-operates in the organisation of ESO’s outstanding e-learning resources, such as weekly e-grandrounds and monthly e-oncoreviews.

Do Not Miss ESO's Next e-Sessions

 
Access this journal onSciVerse ScienceDirect
Print or Share This Page

About Critical Reviews in Oncology/Hematology

Critical Reviews in Oncology / Hematology (CROH) publishes scholarly, critical reviews in all fields of oncology and hematology written by experts from the five continents. All review articles, invited or submitted spontaneously, are subject to peer review before final acceptance. CROH is the Official Journal of the European School of Oncology (ESO) as of January 2011.

Journal Access

Full-text articles are available from 1997 to the present. Access to abstracts is complimentary. Access to full text is limited to print subscribers. Register or login to:

Buy a Subscription Now

Activate Online Access

Publishing Information

Critical Reviews in Oncology / Hematology is published by Elsevier.

Elsevier